Coverage
-
October 02, 2017
Pfizer Inc. fell short of proving the disclosure of its drug pricing and rebate information to two state legislators by the Texas Health and Human Services Commission was a violation of the Federal Medicaid Confidentiality Provision, a federal judge in Texas found on Friday, denying the pharmaceutical giant's bid for an injunction against the commission.
3 other articles on this case.
View all »